01877 JUNSHI BIO
- 11.260
- +0.200+1.81%
JUNSHI BIO News
JUNSHI BIO: Overseas regulatory announcement - JUNSHI BIO Technology Co., Ltd. voluntarily discloses the announcement regarding the regular approval from the National Medical Products Administration for Treprilir Monoclonal Antibody for second-line and above treatment of melanoma.
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
JUNSHI BIO: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JUNSHI BIO: ELECTION OF INDEPENDENT NON-EXECUTIVE DIRECTORSCHANGE IN COMPOSITION OF THE AUDIT COMMITTEE ANDTHE STRATEGIC COMMITTEE
JUNSHI BIO: ARTICLES OF ASSOCIATION
JUNSHI BIO: Overseas regulatory announcement.
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
JUNSHI BIO: FORM OF PROXY FOR THE 2024 FIRST EXTRAORDINARY GENERAL MEETINGTO BE HELD ON FRIDAY, 20 DECEMBER 2024
JUNSHI BIO: PROPOSED ELECTION AND RESIGNATIONOF INDEPENDENT NON-EXECUTIVE DIRECTORS
JUNSHI BIO: (1) CHANGE OF REGISTERED ADDRESS IN THE PRC, PROPOSEDAMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THEINDUSTRIAL AND COMMERCIAL REGISTRATION OF THE CHANGES(2) CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS INHONG KONG
JUNSHI BIO: OVERSEAS REGULATORY ANNOUNCEMENT
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT -NEW INDICATIONS OF TUOYI HAVEBEEN INCLUDED IN THE NATIONALREIMBURSEMENT DRUG LIST
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT -ENTERING INTO OF THE LICENSE AGREEMENT
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT -APPROVAL BY THE MHRA FOR MARKETING OF TORIPALIMAB
JUNSHI BIO: OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON THE COMPLETION OF THE PLAN FOR THE REDUCTION IN THE SHAREHOLDING OF THE SHAREHOLDERS HOLDING MORE THAN 5% OF THE SHARES AND THE RESULT OF THE PLAN FOR THE REDUCTION
JUNSHI BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
No Data
